RWell by RespondWellCheck Eligibility
    Enclomiphene treatment

    Enclomiphene

    Boost testosterone naturally, no injections

    First order: $110

    Second and subsequent refills $130/per 30-day supply of medication Automatic refills – pause, delay or cancel anytime – just make those changes at least 48 hours before your next refill date.

    Prescription Required
    Doctor Prescribed
    100% Online
    UPS 2nd Day Air
    No Waiting Rooms
    No Membership Fees
    FSA/HSA Eligible
    Check Eligibility →Free provider visit • You pay $0 if not approved
    4 Simple Steps

    How Enclomiphene With RWell Works

    Lab-first, doctor-reviewed, delivered to your door. No video visit required.*

    1

    Order Your Labs

    $69

    Comprehensive men's health panel:

    2

    Get Drawn at Quest

    Walk into any Quest Diagnostics location nationwide. No appointment needed.

    Find a Quest location
    3

    Results in ~5 Days

    If your testosterone level qualifies, we email + text your intake paperwork. No video visit required. 10 minutes, on your phone.

    4

    Meds Within a Week

    Prescription written by a licensed physician and shipped discreetly to your door.

    Founders Pricing — First 30 Patients
    Today
    $69
    Initial Labs
    First Order
    $110
    If qualified
    After
    $130/mo

    Locked-in rate for life. Limited to the first 30 enrolled.

    *Online lab ordering not yet available in NY, NJ, or RI. Timelines reflect average turnaround times and are not guaranteed. *Video visit not required in 41 states.

    Ready to Get Started?

    Check Eligibility for Enclomiphene

    *Enclomiphene citrate is not FDA-approved as a standalone drug. It is the trans-isomer of clomiphene citrate, which is FDA-approved for certain female fertility indications. Compounded enclomiphene has not been reviewed by the FDA for safety, quality, or efficacy.

    1 Kim ED, et al. (2014). Enclomiphene citrate stimulates testosterone production while preventing oligospermia. Fertil Steril. 102(3):720–727.

    2 Saffati, G., et al. (2024). Safety and efficacy of enclomiphene and clomiphene for hypogonadal men. Cureus.